Skip to content

AI-Assisted Retina Imaging Combined with Cardiovascular Ultrasound in Predicting Prognosis and Adverse Events in Post-Myocardial Infarction Patients: A Study on Predictive Value

AI-Assisted Retina Imaging Combined with Cardiovascular Ultrasound in Predicting Prognosis and Adverse Events in Post-Myocardial Infarction Patients: A Study on Predictive Value

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2600117250
Enrollment
Unknown
Registered
2026-01-21
Start date
2026-02-01
Completion date
Unknown
Last updated
2026-01-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Heart attack

Interventions

Experimental group:None
Validation group:None

Sponsors

China-Japan Friendship Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1.Age: 18-80 years old (inclusive); 2.Diagnosis of myocardial infarction; 3.Sign the informed consent form.

Exclusion criteria

Exclusion criteria: 1.Pregnant or lactating women; 2.Participate in other clinical trials that may interfere with the results of this study; 3.Severe cognitive impairment or mental illness; 4.Previous history of heart transplantation or left ventricular assist device implantation; 5.Previous history of liver, lung and kidney transplantation; 6.Glaucoma, pathological myopia, post-retinal surgery and other eye diseases that affect retinal image acquisition; 7.Combined with active infectious diseases or systemic inflammatory response syndrome; 8.Active stage of immune system diseases or currently undergoing hormone or biological therapy; 9.Severe liver dysfunction (Child-Pugh grade C); 10.The terminal stage of diseases in various systems as determined by clinicians, and the life expectancy is less than one year; 11.Severe bleeding and clotting tendency; 12.Other circumstances that do not meet the criteria for inclusion as determined by the research team after joint discussion.

Design outcomes

Primary

MeasureTime frame
Retinal photography;carotid artery ultrasound;Optical Coherence Tomography Image Data;Optical coherence tomography angiography imaging data;Ophthalmic artery ultrasound (ophthalmic artery flow velocity; ophthalmic artery flow resistance; central retinal artery flow velocity; central retinal artery flow resistance);Echocardiography indicators;

Secondary

MeasureTime frame
Blood sugar, blood lipid, hepatic and renal function;

Countries

China

Contacts

Public ContactYue Yin

China-Japan Friendship Hospital

78230426@qq.com+86 10 84206584

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026